Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Haoqin Anti-cold Granules for Acute Upper Respiratory Tract Infection (Wind-heat with Dampness) – Phase II RCT
CTR20240277Phase 2Completed
- Sponsor
- Yusen New Drug
- Start
- Feb 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xiao'er haoqin anti-cold granules in upper respiratory infection (URI), sponsored by Yusen New Drug. Started Feb 2024; status: completed.
02
Drugs
xiao'er haoqin anti-cold granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20240277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240277.